ISPE Hires Healthcare Association Exec As Ceo
ISPE—the International Society for Pharmaceutical Engineering announced today it has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience. He brings to the Society a clear vision for the expansion of its global initiatives and business operations including leveraging technology to extend ISPE’s Membership and educational programs.
“I am certain that with John Bournas’ experience, ISPE is well positioned for continued success,” said Damian Greene, Chairman of the ISPE Board of Directors. Greene added, “ISPE has achieved many major milestones during the past few years, including solidifying partnerships with global regulators and spearheading high profile initiatives such as the Drug Shortages Prevention Plan. Under John’s leadership, ISPE will continue to grow these partnerships and initiatives, building on the pharmaceutical industry knowledge and expertise that exists across our 20,000 strong global Membership.”
John Bournas is currently CEO/Executive Director of the World Federation of Hemophilia (WFH), an international healthcare organization, officially recognized by the World Health Organization and comprised of 127 country-based societies, where he led growth of the group’s mission and awareness raising; executed successful corporate affairs partnerships and evolved the group’s digital delivery of educational programs and content. Prior to WFH, he was Senior Director of International Affairs at the American College of Cardiology, the largest global professional society for cardiologists, where he advanced international membership and Chapter establishment abroad; Senior Director, International at Cardinal Health and was a former diplomat, with postings in Chile, Australia and Japan.
“I am pleased to be joining ISPE at a critical time in the pharma and biopharma industry. With companies increasingly challenged to deliver innovative, high-quality medicines within more competitive constraints, Members look to ISPE’s leadership to stimulate dialog on global issues and to capture and share knowledge on implementation of new processes and methods with greater efficiency. I am eager to connect with Members and industry leaders in building collaborative plans that achieve ISPE’s mission and expand its global footprint”, said Bournas.
John Bournas takes the helm at ISPE on 20 September and will oversee ISPE’s Annual Meeting, 12 – 15 October, 2014 in Las Vegas, NV (http://www.ispe.org/2014-annual-meeting), which will coincide with the opening of the ISPE’s office in Washington, DC to establish a permanent executive presence there.
Mr. Bournas earned his MBA at Macquarie University (Australia); MA, Political Science at Fordham University (New York) and BA, International Studies from Fairleigh Dickinson University (New Jersey).
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA. Visit www.ISPE.org for more information.